Virtual Incision’s RASD weighs just two pounds and is designed to perform the procedure through a smaller incision, potentially reducing recovery time and mitigating the risk of surgical complications.
Johnson & Johnson Group world wide chair Sandi Peterson said: “At Johnson & Johnson Medical Devices Companies, we are committed to broadening our portfolio of products and services to meet the changing needs of our customers around the world.
Researchers from Harvard Medical School, Boston Children’s Hospital and Brigham and Women’s Hospital in the US have developed a paediatric surgical implant that grows along with the child.
Canadian firm Synaptive Medical has introduced its second-generation, high-powered Modus V digital microscope that has a robotic arm to aid neurosurgery.
Medtronic has launched a new surgical navigation system named as StealthStation ENT to help surgeons in treating conditions within the ear, nose, and throat (ENT) anatomy.
According to a global statistics report on medical devices, the global surgical instruments market has witnessed a drastic growth spurt in the past 8 years. In 2010, global sales of surgical instruments reached 12 billion USD, 12.9 billion USD in 2011 and 18.6 billion USD in 2014.
Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced it has entered into a definitive agreement under which CooperSurgical will acquire PARAGARD® (intrauterine copper contraceptive), a product within its global Women’s Health business, in a $1.1 billion cash transaction. PARAGARD® had revenues of approximately $168 million for the trailing twelve month period ending June 30, 2017. This transaction includes Teva’s manufacturing facility in Buffalo, NY, which produces PARAGARD® exclusively.
The clearance for 3D-printed Tesera porous titanium interbody fusion systems has been secured from the US Food and Drug Administration (FDA) by Renovis Surgical Technologies.
Location: New South Wales, Australia Venue Address: DoubleTree by Hilton Beijing 168 Guang An Men Wai Avenue Xi Cheng District Beijing China Date: 07 Aug,2017 – 09 Aug,2017 Organizer: Sarika James Brief Conference Series LLC cordially invites you to participate at the 10th International Conference on Clinical and Surgical Ophthalmology to be held during August 07-09, 2017 at Beijing, China. The theme of the conference is “Exploring the novel research and trends in clinical and surgical ophthalmology” which focuses on the significance of vision and also explore the spectrum of latest technological developments in the field of Ophthalmology. Ophthalmology Conference 2017 maximizes the opportunity to interact with and learn from your peers from across the country and across the globe. Detailed Description: Conference Series LLC cordially invites you to participate at the 10th International Conference on Clinical and Surgical Ophthalmology to be held during August 07-09, 2017 at Beijing, China. ...
According to the Medicine Intelligence Data Investment Pattern Database, Yangqi Medical Chip, committed to becoming a pioneer in precision nuclear medicine, recently announced the completion of tens of millions of yuan in PreA round financing. This round of financing is led by Anfeng Venture Capital, and the raised funds will mainly be used for market promotion of approved products, approval of new product research and development, and expansion of the pet radiotherapy market. Yangqi Medical Core was established in 2021, and its core founding team is composed of clinical experts in nuclear medicine, nuclear physics and artificial intelligence, tumor radiotherapy, and radiation physics from Stanford, Alibaba, and other domestic and foreign institutions. The company is headquartered in Shenzhen and has research and development centers in Hangzhou and Shanghai. It is reported that Yangqi Medical Core is deeply involved in the fields of nuclear medicine and tumor radiation therapy. In response ...
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.